Esperion Therapeutics (ESPR) Debt to Equity (2012 - 2026)
Esperion Therapeutics (ESPR) reported Debt to Equity of -$0.5 for Q1 2026, down 49.4% on a YoY basis from -$0.98 in Q1 2025, and up 1.64% quarter-over-quarter from -$0.5 in Q4 2025.
Esperion Therapeutics (ESPR) Debt to Equity (2012 - 2026) Analysis & Trends
Esperion Therapeutics has reported Debt to Equity for 9 years, with the latest figure at -$0.5 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 49.4% year-over-year to -$0.5; the trailing twelve-month figure through Mar 2026 stood at -$0.5 (down 49.4% YoY), and the FY2025 full-year result was -$0.5, down 39.0% from the prior year.
- Debt to Equity for Q1 2026 stood at -$0.5, up from -$0.5 in the prior quarter.
- The five-year high for Debt to Equity was -$0.33 in Q1 2025, with the low at -$0.5 in Q4 2025.
- Historically, Debt to Equity has averaged -$0.39 across 3 years, with a median of -$0.35 in 2025.
- Annual changes were most pronounced in 2025 — Debt to Equity slumped 39.0% — and 2026, when it plunged 49.4%.
- Esperion Therapeutics' Debt to Equity stood at -$0.36 in 2024, then plunged by 39.0% to -$0.5 in 2025, then increased by 1.64% to -$0.5 in 2026.
- The last three Debt to Equity figures came in at -$0.5 (Q1 2026), -$0.5 (Q4 2025), and -$0.34 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | -0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.50 |
| Dec 31, 2025 | -0.50 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.33 |
| Dec 31, 2024 | -0.36 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.00 |
| Dec 31, 2017 | 0.00 |
| Sep 30, 2017 | 0.01 |
| Jun 30, 2017 | 0.01 |
| Mar 31, 2017 | 0.01 |
| Dec 31, 2016 | 0.01 |
| Sep 30, 2016 | 0.01 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.01 |
| Dec 31, 2015 | 0.01 |
| Sep 30, 2015 | 0.02 |
| Jun 30, 2015 | 0.02 |
| Mar 31, 2015 | 0.02 |